Symrise wins €125m EIB loan for nutrition and skin R&D

Symrise wins €125m EIB loan for nutrition and skin R&D

Related tags Investment Finance Innovation

Cosmetics and nutrition are the focal points for a €125m research and development loan gained by supplier Symrise.

The European Investment Bank money was important for ongoing projects of the German flavours and fragrance that has made big steps toward nutritional projects in recent years including investments in probiotics by way of example.

“Research and development is the foundation of our innovative strength and the basis for our accelerated growth,”​ said Symrise CEO Dr Heinz-Jürgen Bertram.

“For many years, Symrise has invested heavily in the research of innovative fragrances, flavors and functional ingredients, as well as into the development of environmentally friendly technologies and new process techniques.”

“We are delighted that the European Investment Bank is supporting us in this area as a financing partner with a long-term perspective. This recognises our activities and gives us an incentive to continue along our high standards of innovation, quality and consumer awareness.”

The work will occur in its Life Essentials and Consumer Health business units. Symrise employs more than 100 people in R&D.

Symrise recently bought a 15% stake in Swedish probiotics supplier Probi and the two companies are working on oral and other products in that area.

It had a turnover of €1.6bn in 2011.

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 08-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

HRB probiotics in the HMO era

HRB probiotics in the HMO era

Content provided by Morinaga Milk Industry Co., Ltd. | 29-Apr-2024 | White Paper

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 26-Apr-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Related suppliers

Follow us

Products

View more

Webinars